Search research articles
Contact Us
Filters
Showing results (41-50 of 130) with videos related to
Page
of 13
Sort By:
JAMA Dermatology
|
December 15, 2021
Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis: 1-Year Results From the RELIEVE-AD Study
Bruce Strober, Usha G Mallya, Min Yang, et al.
Dermatology and Therapy
|
April 15, 2025
Management of Challenging Psoriasis Clinical Scenarios
Linda Stein Gold, Andrew Alexis, Brad P Glick, et al.
Dermatology and Therapy
|
July 2, 2025
Real-World Skin Clearance and Quality of Life with risankizumab in Patients with Psoriasis with Moderate Skin Involvement and Those Eligible for Systemic Therapy Per International Psoriasis Council Classification
Bruce Strober, Manish Patel, Mark I Kaldas, et al.
Psoriasis (Auckland, N.Z.)
|
December 3, 2024
The Association Between Patient-Reported Disease Burden and Treatment Switching in Patients with Plaque Psoriasis Treated with Nonbiologic Systemic Therapy
Vardhaman Patel, Sang Hee Park, Yichen Zhong, et al.
BMJ Open
|
April 22, 2019
Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry
Bruce Strober, Jeffrey D Greenberg, Chitra Karki, et al.
Journal of the American Academy of Dermatology
|
March 6, 2024
Mental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab: Analysis of phase 2/3 randomized trials
Andrew Blauvelt, April Armstrong, Joseph F Merola, et al.
The Journal of Clinical and Aesthetic Dermatology
|
October 30, 2013
Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2013 MauiDerm Meeting
Andrew Blauvelt, Marc Brown, Kenneth B Gordon, et al.
Journal of Drugs in Dermatology : JDD
|
August 16, 2017
Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study
Bruce Strober, Jerry Bagel, Mark Lebwohl, et al.
Clinical Pharmacology in Drug Development
|
June 2, 2018
Pharmacokinetic Characteristics of Tofacitinib in Adult Patients With Moderate to Severe Chronic Plaque Psoriasis
Guangli Ma, Rujia Xie, Bruce Strober, et al.
Dermatology and Therapy
|
November 8, 2025
Comparison of All-Cause Mortality in Generalized Pustular Psoriasis and Plaque Psoriasis: A Systematic Review and Meta-Analysis
Bruce Strober, Lluís Puig, Mark G Lebwohl, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 130) with videos related to
Sort By:
Page
of 13
JAMA Dermatology
|
December 15, 2021
Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis: 1-Year Results From the RELIEVE-AD Study
Bruce Strober, Usha G Mallya, Min Yang, et al.
Dermatology and Therapy
|
April 15, 2025
Management of Challenging Psoriasis Clinical Scenarios
Linda Stein Gold, Andrew Alexis, Brad P Glick, et al.
Dermatology and Therapy
|
July 2, 2025
Real-World Skin Clearance and Quality of Life with risankizumab in Patients with Psoriasis with Moderate Skin Involvement and Those Eligible for Systemic Therapy Per International Psoriasis Council Classification
Bruce Strober, Manish Patel, Mark I Kaldas, et al.
Psoriasis (Auckland, N.Z.)
|
December 3, 2024
The Association Between Patient-Reported Disease Burden and Treatment Switching in Patients with Plaque Psoriasis Treated with Nonbiologic Systemic Therapy
Vardhaman Patel, Sang Hee Park, Yichen Zhong, et al.
BMJ Open
|
April 22, 2019
Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry
Bruce Strober, Jeffrey D Greenberg, Chitra Karki, et al.
Journal of the American Academy of Dermatology
|
March 6, 2024
Mental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab: Analysis of phase 2/3 randomized trials
Andrew Blauvelt, April Armstrong, Joseph F Merola, et al.
The Journal of Clinical and Aesthetic Dermatology
|
October 30, 2013
Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2013 MauiDerm Meeting
Andrew Blauvelt, Marc Brown, Kenneth B Gordon, et al.
Journal of Drugs in Dermatology : JDD
|
August 16, 2017
Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study
Bruce Strober, Jerry Bagel, Mark Lebwohl, et al.
Clinical Pharmacology in Drug Development
|
June 2, 2018
Pharmacokinetic Characteristics of Tofacitinib in Adult Patients With Moderate to Severe Chronic Plaque Psoriasis
Guangli Ma, Rujia Xie, Bruce Strober, et al.
Dermatology and Therapy
|
November 8, 2025
Comparison of All-Cause Mortality in Generalized Pustular Psoriasis and Plaque Psoriasis: A Systematic Review and Meta-Analysis
Bruce Strober, Lluís Puig, Mark G Lebwohl, et al.
Page
of 13